PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Sermorelin & GHRP-6 & GHRP-2, Viking 1
A triple research blend pairing the GHRH analog Sermorelin with two ghrelin-receptor agonists, GHRP-6 and GHRP-2. It is studied for maximal synergistic stimulation of endogenous growth hormone.
Sign in to rate this peptide.
Sermorelin (GHRH 1-29) binds the pituitary GHRH receptor to promote GH synthesis and release, while GHRP-6 and GHRP-2 both activate the GHS-R1a (ghrelin) receptor to evoke additional GH pulses and suppress somatostatin. Combining a GHRH analog with two complementary GHRPs is intended to maximize the amplitude of pulsatile GH secretion. The blend leverages multiple receptor inputs to drive downstream hepatic IGF-1 production while preserving the natural feedback architecture of the GH axis.